Workboat Indexes

Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Workboat Indexes
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Panbela Therapeutics Inc (NQ: PBLA )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Mar 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Panbela Therapeutics Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
PBLA Stock Earnings: Panbela Therapeutics Misses EPS for Q1 2024
PBLA stock results show that Panbela Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac
Developed in collaboration with Sanofi. 
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Recap: Panbela Therapeutics Q4 Earnings
Via Benzinga
Earnings Preview: Panbela Therapeutics
Via Benzinga
Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025
Trial's lower-than-expected event rate suggests improved survival outcomes 
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Panbela Announces Poster Presentation at American Association for Cancer Research:
Ivospemin/doxorubicin combination modulates polyamine metabolism to improve survival in murine ovarian cancer models 
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Panbela Announces Transfer to OTCQB Market
From Panbela Therapeutics, Inc.
Via GlobeNewswire
PBLA Stock Earnings: Panbela Therapeutics Misses EPS for Q4 2023
PBLA stock results show that Panbela Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Panbela to Host Fourth Quarter and Year End 2023 Earnings Conference Call on March 26, 2024
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Top 4 Health Care Stocks That Are Preparing To Pump This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Panbela Regains Compliance with Nasdaq Listing Standards for Bid Price and Publicly Held Shares Requirements
From Panbela Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
BioMedNewsBreaks – Panbela Therapeutics Inc. (NASDAQ: PBLA) Secures ~$9M in Public Offering
Via Investor Brand Network
Panbela Announces Closing of Approximately $9.0 Million Public Offering
From Panbela Therapeutics, Inc.
Via GlobeNewswire
What's Going On With Panbela Therapeutics Stock Today?
Panbela Therapeutics announced acceptance of SBP-101 abstract for presentation and disclosed details of a public offering, expecting approximately $9.0 million in gross proceeds. 
Via Benzinga
Acceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR)
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Crude Oil Down Over 1%; Science 37 Holdings Shares Spike Higher
U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 75 points on Monday. The Dow traded up 0.03% to 38,121.11 while the NASDAQ rose 0.48% to... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Dow Edges Lower; Cardlytics Shares Jump
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 20 points on Monday. The Dow traded down 0.04% to 38,093.41 while the NASDAQ rose 0.15% to 4,891.83. The S&P... 
Via Benzinga
Topics Stocks
Exposures US Equities
US Stocks Edge Higher; Amazon And iRobot Agree To Terminate Acquisition Deal
U.S. stocks traded slightly higher this morning, with the Dow Jones index gaining around 25 points on Monday. Following the market opening Monday, The Dow traded up 0.07% to 38,134.80 while the NASDAQ... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Aclarion (ACON) Stock Down 16% Today?
Aclarion stock is falling on Monday after the company issued 500,000 shares of ACON to cover principal and accrued interest from notes. 
Via InvestorPlace
Why Is Panbela Therapeutics (PBLA) Stock Down 63% Today?
Panbela Therapeutics stock is falling on Monday after pricing a public offering for PBLA shares well below its price closing price. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why ZIM Integrated Shipping Services Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) shares rose sharply in today's pre-market trading after Jefferies upgraded the stock from Hold to Buy and raised its price target from $14 to $20. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start the trading week with a dive into the biggest pre-market stock movers worth watching on Monday morning! 
Via InvestorPlace
Panbela Announces Pricing of Approximately $9.0 Million Public Offering
From Panbela Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Diversified Communications
© 2024 Diversified Communications. All rights reserved.